Eight years after cannabis-based medicines became available for prescription in the UK, the conversation has moved on. The challenge is no longer simply establishing that medical cannabis exists within healthcare, but understanding how evidence, prescribing practice, governance, regulation and patient access should develop from here.

The London Symposium will bring together healthcare professionals, researchers, policymakers, patient organisations and responsible industry professionals to examine those questions from different perspectives.

The programme will cover the latest clinical evidence for cannabis-based medicines across a range of conditions, UK policy and regulatory developments affecting patient access, prescribing guidance and governance, patient experiences and lived perspectives, emerging research and practical insights from clinicians already working within medical cannabis.

Keynote presentations, expert panel discussions and audience Q&A will provide opportunities for informed discussion and knowledge sharing across professions that do not always have the opportunity to sit in the same room.

The Symposium is aimed at doctors and specialist clinicians, GPs and prescribing healthcare professionals, pharmacists, nurses, researchers, academics, policymakers, regulators, patient and advocacy organisations and responsible businesses working within the sector.

For the UK medical cannabis sector, the value of events such as this lies in connecting clinical evidence with practical experience and ensuring that patient access remains part of the wider conversation about how the sector develops.

Members, supporters and followers can receive 10% off tickets using the discount code:

CTA10

Book London Tickets